Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data

INTRODUCTION: Advanced papillary thyroid cancer (PTC) has a poor prognosis, 60~70% of which become radio iodine refractory (RAI-R), but the molecular markers that assess PTC progress to advanced PTC remain unclear. Meanwhile, current targeted therapies are badly effective due to drug resistance and...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hui, Cong, Shan, Wang, Yu, Ji, Qinghai, Liu, Weiyan, Qu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744787/
https://www.ncbi.nlm.nih.gov/pubmed/36523593
http://dx.doi.org/10.3389/fendo.2022.969914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744787/
https://www.ncbi.nlm.nih.gov/pubmed/36523593
http://dx.doi.org/10.3389/fendo.2022.969914

Ejemplares similares